Kyushu Railway Company has sold 51% of the shares of JR Kyushu Drug Eleven Co.,Ltd. to Tsuruha Holdings Inc
Tokyo – Frontier Management Inc. (CFI Japan) is pleased to announce that they acted as financial advisor to Kyushu Railway Company in the sale of 51% of the shares of JR Kyushu Drug Eleven Co.,Ltd. to Tsuruha Holdings Inc. After this transfer, JR Kyushu will continue to hold 49% of the shares of Drug Eleven.
Drug Eleven operates in accordance with its corporate philosophy of finding joy in the health, beauty, and satisfaction of customers and contributing to local communities with a feeling of gratitude. On that basis, Drug Eleven has developed the drugstore business, principally in the Kyushu and Okinawa regions, as a core subsidiary in the JR Kyushu Group’s Retail and Restaurant segment. In particular, Drug Eleven has rolled out stores in a variety of formats in line with local community characteristics and customer usage scenarios.
TSURUHA HOLDINGS INC. is a holding company which manages subsidiaries that operate drug stores in Hokkaido and the Tohoku area. The Company’s product line includes drugs, cosmetics, and household utensils.
The transaction closed in May 2020.
Related
Our latest transactions
Aerospace & Defence
has been acquired by
backed by
Transaction details
Aviotec, an Italian aerospace insulation and harness solutions provider, has been acquired by Canopy Aerospace & Defence, backed Trive Capital
Business Services
partners with
backed by
Transaction details
Westerduin, a Dutch staffing specialist, partners with Werkis, backed by Quadrum Capital
Business Services
has been acquired by
Transaction details
Honk & Sandström, a Swedish traffic and track safety consultant, has been acquired by railway infrastructure company group Rovik Group
Business Services
has acquired
Transaction details
Independent international consultancy R&D specialist Zabala Innovation Consulting has acquired ECDF
